Mirum Pharmaceuticals, Inc. (MIRM) insider trading.
In Q3 2026, insiders at Mirum Pharmaceuticals, Inc. reported 24 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 19 sales worth $14.2M.
- Transactions
- 24
- Purchases (P)
- 0
- Sales (S)
- 19
- Net shares, P minus S
- -136,163
- Insiders
- 3
- Last filed
- 2026-09-15
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Peetz Christopher | Director, Officer · CHIEF EXECUTIVE OFFICER | 12 | 0 | 9 |
| Bjerkholt Eric | Officer · CHIEF FINANCIAL OFFICER | 7 | 0 | 6 |
| Howe Jolanda | Officer · SVP, GLOBAL CONTROLLER | 5 | 0 | 4 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Bjerkholt Eric | S (D) | 9,943 | $98.37 | 44,745 | Form 4 |
| 2026-09-11 | Bjerkholt Eric | M (A) | 18,333 | — | 54,688 | Form 4 |
| 2026-09-02 | Howe Jolanda | S (D) | 658 | $100 | 616 | Form 4 |
| 2026-09-01 | Peetz Christopher | S (D) | 8,312 | $98.08 | 216,128 | Form 4 |
| 2026-09-01 | Peetz Christopher | M (A) | 30,000 | $2.94 | 224,440 | Form 4 |
| 2026-09-01 | Peetz Christopher | S (D) | 21,688 | $98.91 | 194,440 | Form 4 |
| 2026-08-18 | Howe Jolanda | S (D) | 40,000 | $100 | 1,274 | Form 4 |
| 2026-08-18 | Howe Jolanda | M (A) | 40,000 | $6.27 | 41,274 | Form 4 |
| 2026-08-11 | Bjerkholt Eric | S (D) | 6,001 | $99.9 | 36,355 | Form 4 |
| 2026-08-10 | Peetz Christopher | S (D) | 6,017 | $99.25 | 196,609 | Form 4 |
| 2026-08-10 | Peetz Christopher | M (A) | 20,000 | $2.94 | 214,309 | Form 4 |
| 2026-08-10 | Peetz Christopher | S (D) | 11,683 | $98.51 | 202,626 | Form 4 |
| 2026-08-10 | Peetz Christopher | S (D) | 2,300 | $100.14 | 194,309 | Form 4 |
| 2026-08-03 | Howe Jolanda | S (D) | 1,840 | $105.29 | 1,274 | Form 4 |
| 2026-07-06 | Bjerkholt Eric | S (D) | 300 | $124.94 | 42,181 | Form 4 |
| 2026-07-06 | Bjerkholt Eric | S (D) | 528 | $123.84 | 42,481 | Form 4 |
| 2026-07-06 | Bjerkholt Eric | S (D) | 1,048 | $122.43 | 43,009 | Form 4 |
| 2026-07-06 | Bjerkholt Eric | S (D) | 3,124 | $121.67 | 44,057 | Form 4 |
| 2026-07-06 | Peetz Christopher | M (A) | 20,000 | $2.94 | 214,309 | Form 4 |
| 2026-07-06 | Peetz Christopher | S (D) | 12,134 | $121.65 | 202,175 | Form 4 |
| 2026-07-06 | Peetz Christopher | S (D) | 4,181 | $122.34 | 197,994 | Form 4 |
| 2026-07-06 | Peetz Christopher | S (D) | 1,710 | $124.79 | 194,309 | Form 4 |
| 2026-07-06 | Peetz Christopher | S (D) | 1,975 | $123.74 | 196,019 | Form 4 |
| 2026-07-01 | Howe Jolanda | S (D) | 2,721 | $120 | 3,114 | Form 4 |
Transaction codes in this quarter
Get MIRM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1759425&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · MIRM company page · Mirum Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Mirum Pharmaceuticals, Inc. (MIRM)?
In Q3 2026, insiders at Mirum Pharmaceuticals, Inc. reported 24 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 19 sales worth $14.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Mirum Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/mirm.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.